Back to Trades
Pamir Ozan
Chief Financial OfficerCIK 0001834681
Profile
- Filings
- 3
- Buy transactions
- 2
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Pamir Ozan, Chief Financial Officer, has disclosed $364.1K in transactions — all concentrated in Niagen Bioscience, Inc. (NAGE). Their disclosed trades are heavily weighted toward buying — $45.6K in buys and $0 in sells. The largest single open-market purchase on record is $45.6K in Niagen Bioscience, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jul 8 | NAGE Niagen Bioscience, Inc. | Pamir Ozan | Chief Financial Officer | Grant | $11.5K |
| Feb 24 | NAGE Niagen Bioscience, Inc. | Pamir Ozan | Chief Financial Officer | Award | $306.9K |
| Nov 17 | NAGE Niagen Bioscience, Inc. | Pamir Ozan | Chief Financial Officer | Buy | $45.6K |
3 filings